The Surge In Inflammatory Bowel Diseases Spurs Growth In Treatment Market: A Key Driver Powering Inflammatory Bowel Disease Treatment Market Growth In 2025

The Inflammatory Bowel Disease Treatment Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

What Is the Current Inflammatory Bowel Disease Treatment Market Size and Its Estimated Growth Rate?
The market size for the treatment of inflammatory bowel disease has experienced significant growth lately. It is projected to expand from a value of $25.26 billion in 2024 to $27.45 billion in 2025, indicating a compound annual growth rate (CAGR) of 8.6%. This growth during the historic period is linked to several factors including a rise in inflammatory bowel disease incidences, an upsurge in demand for biologics and immunomodulators, advances in treatment methods, an increasing elderly population, and heightened awareness of the disease.

The market for treatment for inflammatory bowel disease is set to witness considerable expansion in the coming years, growing to a robust $40.27 billion by 2029, recording a compound annual growth rate of 10.1%. This predicted growth for the foreseeable period can be credited to an increase in funding for research and innovation, increasing demand for biosimilars, expansion of inflammatory bowel disease in emerging markets, growing requirements for customised medicine, and the adoption of precision medicine in IBD therapy. Noteworthy trends projected for the forecast period include the rise in product introductions and approvals, customed dosing and treatment strategies in IBD management, the deployment of telemedicine for the remote supervision of IBD patients, the investigation of microbiome-oriented therapies for IBD, and the embracement of value-based care plans in IBD treatment.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=6704

How Are Emerging Segments Shaping the Inflammatory Bowel Disease Treatment Market Landscape?
The inflammatory bowel disease treatment market covered in this report is segmented -

1) By Drug Class: Aminosalicylates, Corticosteroids, TNF inhibitors, IL inhibitors, Anti-integrin, JAK inhibitors, Other Drug Classes
2) By Type: Crohn's Disease, Ulcerative Colitis
3) By Route Of Administration: Oral, Injectable
4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy

Subsegments:
1) By Aminosalicylates: Mesalamine, Sulfasalazine, Balsalazide
2) By Corticosteroids: Prednisone, Budesonide, Hydrocortisone
3) By TNF Inhibitors: Infliximab, Adalimumab, Certolizumab pegol
4) By IL Inhibitors: Ustekinumab, Guselkumab
5) By Anti-Integrin: Vedolizumab, Natalizumab
6) By JAK Inhibitors: Tofacitinib, Filgotinib
7) By Other Drug Classes: Antibiotics, Immunosuppressants, Other Novel Therapies

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=6704&type=smp

Which Growth Factors Are Influencing Inflammatory Bowel Disease Treatment Market Expansion?
The increase in incidences of Crohn's disease and ulcerative colitis is substantially fuelling the market for inflammatory bowel disease treatments. Crohn's disease and ulcerative colitis are various forms of inflammatory bowel diseases (IBD) that result in swelling and ulcers (sores) in the digestive system. The escalating cases of these ailments are anticipated to enhance the demand for treatments for inflammatory bowel disease since they are commonly employed to lessen inflammation in the bowels and to curtail and prevent medical issues. As an example, research disclosed in March 2022 by the United States National Library of Medicine, a medical library situated in the US, states that nearly 1.6 million Americans are presently grappling with inflammatory bowel disease (Crohn's disease or ulcerative colitis) and there are approximately 70,000 fresh cases of IBD diagnosed annually in the USA. Consequently, the mounting incidence of Crohn's disease and ulcerative colitis is predicted to spur the growth of the market for inflammatory bowel disease treatment.

Who Are the Dominant Players Across Different Inflammatory Bowel Disease Treatment Market Segments?
Major companies operating in the inflammatory bowel disease treatment market include AbbVie Inc., Biogen Inc., Johnson & Johnson, Amgen Inc., Advanced Gastroenterology and Surgery Associates P. A., Atlanta Gastroenterology Associates LLC, Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Company, Cedars-Sinai Medical Center, Celgene Corporation, Cleveland Clinic Foundation, Digestive Disease Associates of Rockland P. C., Eli Lilly and Company, Gastrointestinal Specialists Inc., Gilead Sciences Inc., GlaxoSmithKline plc, Illinois Gastroenterology Group LLC, The Johns Hopkins Hospital Inc., Massachusetts General Hospital, Mayo Clinic, Merck & Co. Inc., Mount Sinai Health System Inc., Novartis International AG, Pfizer Inc., F. Hoffmann-La Roche Ltd, Takeda Pharmaceutical Company Limited, Texas Digestive Disease Consultants P. A., The Oregon Clinic - Gastroenterology West P. C., Salix Pharmaceuticals Inc., Vifor Pharma AG, Zydus Pharmaceuticals (USA) Inc.

What Are the Latest Developing Trends in the Inflammatory Bowel Disease Treatment Market?
The increasing significance of technological innovation is a significant trend that is gaining momentum in the inflammatory bowel disease treatment market. Many leading companies in this market are adopting AI-driven registries to achieve competitive advantages. For example, Verantos, a California-based company specializing in real-world evidence (RWE), introduced the Inflammatory Bowel Disease Pragmatic Registry in May 2024, utilizing cutting-edge artificial intelligence to generate substantial real-world evidence for ulcerative colitis and Crohn's disease. The registry serves to assist in the creation of effective treatments by offering a complete dataset comprising more than 3 billion data points about patient care. This allows biopharma researchers to gain in-depth understanding of disease severity, efficacy of treatment, and clinical results by analyzing both structured and unstructured data extracted from electronic health records.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/inflammatory-bowel-disease-treatment-global-market-report

Which Geographic Regions Are Expected to Dominate the Inflammatory Bowel Disease Treatment Market in the Coming Years?
North America was the largest region in the inflammatory bowel disease treatment market in 2024.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the inflammatory bowel disease treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Inflammatory Bowel Disease Treatment Market?
2. What is the CAGR expected in the Inflammatory Bowel Disease Treatment Market?
3. What Are the Key Innovations Transforming the Inflammatory Bowel Disease Treatment Industry?
4. Which Region Is Leading the Inflammatory Bowel Disease Treatment Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.